pharmaphorum August 28, 2024
Phil Taylor

A virtual voice assistant that calls patients after heart procedures can allow them to be discharged from hospital earlier and identify patients who may need follow-up interventions, according to a new study.

The TeleTAVI trial was carried out in 274 people with a narrowing (stenosis) of the aortic valve who needed a replacement implanted and used a voice assistant called Lola, created by the Spanish company Tucuvi. It will be presented at the European Society of Cardiology (ESC) annual congress that gets underway in London on Friday.

In the study, patients undergoing a transcatheter aortic valve implantation (TAVI) procedure were given the option of receiving follow-up telephone calls with the voice assistant, which uses artificial intelligence and natural language processing...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: AI (Artificial Intelligence), Patient / Consumer, Provider, Technology, Voice Assistant
Related Articles:
Balancing AI Expertise and Industry Acumen in Vertical Applications
Companies may be more liable for genAI use than they think
7 Futuristic Professions In Healthcare You Can Still Prepare For - 2
Where healthcare AI startups are raising venture capital funding
Report: OpenAI Must Alter Structure to Reach $150 Billion Valuation

Share This Article